PCS-2023: 3E0L Introduction, Pleural Cavity

PCS-2023 > 3 > 3E > 3E0 > 3E0L

3E0	Physiological Systems and Anatomical Regions, Introduction
	Info:	Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
3E0L	Introduction, Pleural Cavity
3E0L0	Open
3E0L05	Adhesion Barrier
3E0L05Z	Introduction of Adhesion Barrier into Pleural Cavity, Open Approach
3E0L3	Percutaneous
3E0L30	Antineoplastic
3E0L304	Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Percutaneous Approach
3E0L305	Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach
3E0L30M	Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach
3E0L32	Anti-infective
3E0L328	Introduction of Oxazolidinones into Pleural Cavity, Percutaneous Approach
3E0L329	Introduction of Other Anti-infective into Pleural Cavity, Percutaneous Approach
3E0L33	Anti-inflammatory
3E0L33Z	Introduction of Anti-inflammatory into Pleural Cavity, Percutaneous Approach
3E0L35	Adhesion Barrier
3E0L35Z	Introduction of Adhesion Barrier into Pleural Cavity, Percutaneous Approach
3E0L36	Nutritional Substance
3E0L36Z	Introduction of Nutritional Substance into Pleural Cavity, Percutaneous Approach
3E0L37	Electrolytic and Water Balance Substance
3E0L37Z	Introduction of Electrolytic and Water Balance Substance into Pleural Cavity, Percutaneous Approach
3E0L3B	Anesthetic Agent
3E0L3BZ	Introduction of Anesthetic Agent into Pleural Cavity, Percutaneous Approach
3E0L3H	Radioactive Substance
3E0L3HZ	Introduction of Radioactive Substance into Pleural Cavity, Percutaneous Approach
3E0L3K	Other Diagnostic Substance
3E0L3KZ	Introduction of Other Diagnostic Substance into Pleural Cavity, Percutaneous Approach
3E0L3N	Analgesics, Hypnotics, Sedatives
3E0L3NZ	Introduction of Analgesics, Hypnotics, Sedatives into Pleural Cavity, Percutaneous Approach
3E0L3T	Destructive Agent
3E0L3TZ	Introduction of Destructive Agent into Pleural Cavity, Percutaneous Approach
3E0L3G	Other Therapeutic Substance
3E0L3GC	Introduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Approach
3E0L3S	Gas
3E0L3SF	Introduction of Other Gas into Pleural Cavity, Percutaneous Approach
3E0L4	Percutaneous Endoscopic
3E0L45	Adhesion Barrier
3E0L45Z	Introduction of Adhesion Barrier into Pleural Cavity, Percutaneous Endoscopic Approach
3E0L4G	Other Therapeutic Substance
3E0L4GC	Introduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Endoscopic Approach
3E0L7	Via Natural or Artificial Opening
3E0L70	Antineoplastic
3E0L704	Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Via Natural or Artificial Opening
3E0L705	Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening
3E0L70M	Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening
3E0L7S	Gas
3E0L7SF	Introduction of Other Gas into Pleural Cavity, Via Natural or Artificial Opening

and

Physiological Systems and Anatomical Regions, Introduction

Introduction, Pleural Cavity